Common Stock SEC Reporting - Delinquent
OTC Pink No Information
Contact Info
  • 8250 Exchange Drive
  • Suite 120
  • Orlando, FL 32809

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
CIK 0000941020
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 8071 - Medical laboratories
Incorporated In: PA, USA
Year of Inc. 1994
Employees Not Available
Company Officers/Contacts
Bernard L. Kasten, Jr. MD President, CEO
Michael G. Smith Interim CFO, COO
Company Directors
Bernard L. Kasten, Jr. MD Chairman
Douglas Boyle
Richard Ricciardi
Company Notes
  • Note = On April 18, 2014 GeneLink, Inc. filed a voluntary petition for reorganization for itself and its subsidiaries under Chapter 11 of Title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Florida
  • Note=12-98 company is in the development stage
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
GNLKQ Security Details
Share Structure
Market Value1 $79,506 a/o Aug 18, 2017
Authorized Shares 350,000,000 a/o May 27, 2011
Outstanding Shares 265,018,689 a/o Nov 08, 2013
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value 0.01
Transfer Agent(s)
Shareholders of Record 218 a/o Apr 01, 2013
Short Selling Data
Short Interest 0 (-100%)
Mar 13, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security